A poilot study of eribulin monotherapy in chemorefractory patients with BRAF V600E-mutant metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2642859
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Eribulin 1.4 mg/m2 days 1 and 8 (repeated every 21 days)
Primary outcome(s): Objective response rate; ORR
Study Design: Single arm Non-randomized
创建时间：
2017-06-15
